Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma
<sup>123</sup>I-meta-iodobenzylguanidine (<sup>123</sup>I-mIBG) scintigraphy is used for evaluating disease extent in children with neuroblastoma. <sup>131</sup>I-mIBG therapy has been used for evaluation in children with high-risk neuroblastoma, and post-therapy...
Main Authors: | Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda, Norihito Akatani, Takafumi Yamase, Satoru Watanabe, Tomo Hiromasa, Yuji Kunita, Hiroshi Mori, Shintaro Saito, Yasuhiro Ikawa, Toshihiro Fujiki, Seigo Kinuya |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/10/9/663 |
Similar Items
-
Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments
by: Atia Samim, et al.
Published: (2021-04-01) -
MIBG Therapy for Neuroblastoma: Precision Achieved With Dosimetry, and Concern for False Responders
by: Pedro M. Rubio, et al.
Published: (2020-05-01) -
QUANTITATIVE APPROACH TO ASSIST NEUROBLASTOMA ASSESSMENT BY MEASURING I-123 mIBG UPTAKE IN SCINTIGRAPHIC IMAGES
by: Rafael Martínez-Díaz, et al.
Published: (2015-03-01) -
Upfront consolidation treatment with 131I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma
by: Jianhua Feng, et al.
Published: (2020-09-01) -
Renal <sup>123</sup>I-MIBG Uptake before and after Live-Donor Kidney Transplantation
by: Thomas Rasmussen, et al.
Published: (2020-10-01)